Fiona Cowden

Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial

John Marsden, Mike Kelleher, Éilish Gilvarry et al. · EClinicalMedicine · 2023 · 39 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone

John Marsden, Mike Kelleher, Zoë Hoare et al. · Trials · 2022 · 11 citations · Full text

Nursing, Pharmacoeconomics, Pharmacotherapy +16

Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study

Catherine Best, Catriona Matheson, James R. Robertson et al. · BMJ Open · 2024 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13